Introduction {#sec1-1}
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Two to eight per cent (2-8%) of all pregnancies worldwide are complicated by pre-eclampsia causing over 63,000 maternal deaths annually \[[@ref1]\]. The maternal mortality rate of pre-eclampsia is highest in low and middle income countries. However, pre-eclampsia is still a life-threatening disorder even in developed countries \[[@ref2]\]. There is a five-fold increase in perinatal deaths from intrauterine growth restriction and prematurity as a result of pre-eclampsia \[[@ref3]\]. Preterm birth in itself is responsible for the majority of neonatal deaths and nearly one half of all cases of congenital neurologic disability \[[@ref4]\]. Fifteen percent (15%) of all premature deliveries in the United States (US) are as a result of pre-eclampsia \[[@ref3]\]. The aetiology of pre-eclampsia lies in the placenta though it remains unknown \[[@ref5]\]. Pre-eclampsia is known to occur only in the presence of a placenta as in for example molar pregnancy and resolves after its delivery. Placental growth is a regulated process and it is vital for normal foetal development and for maintenance of successful pregnancy. Normal placental development requires that cytotrophoblast invades the maternal spiral arterioles \[[@ref5]\]. There is an impairment of cytotrophoblastic invasion of the myometrial portion of the spiral arteries in pre-eclampsia leading to narrowing of the spiral arteries with limited blood supply to the foetus \[[@ref6]\]. This eventually causes placental ischaemia and microinfarction with subsequent release of placental factors leading to an imbalance in angiogenic factors and therefore widespread endothelial dysfunction that is seen in pre-eclampsia \[[@ref6]\]. The ability of the maternal system to handle the deficits in placentation and subsequent challenge to the maternal cardiovascular system partly depend on the immune system, as systemic inflammatory stress plays a key role in endothelial cell activation \[[@ref6]\].

Nitric oxide (NO), a vascular endothelial relaxant may be involved in the development of pre-eclampsia. An endothelial form of NO synthase has been localised to the syncytiotrophoblast and villous endometrium in term pregnancies \[[@ref5]\] \[[@ref6]\]. The placenta is, therefore, an important source of NO during pregnancy. Various animal models in which NO synthesis has been inhibited have been associated with symptoms such as hypertension, proteinuria, thrombocytopenia and restricted foetal growth \[[@ref5]\] \[[@ref6]\]. The main placental vasodilator is nitric oxide, and it regulates placental vascular resistance and reactivity, apoptosis and invasion by trophoblast, and aggregation and adhesion of platelets in the placental bed \[[@ref7]\]. Numerous studies hold the view that pre-eclampsia is a multisystem disorder with vascular endothelial dysfunction, however, as to whether the change in the function of the endothelium noted in pre-eclampsia results in a decrease, an increase or an unchanged endothelial NO synthesis is still debatable \[[@ref8]\].

Literature has reported inconsistent results as far as serum nitric oxide levels in pre-eclampsia compared to healthy pregnant women is concerned. Various studies have reported raised serum nitric oxide levels \[[@ref9]\] while others have reported non-significant change \[[@ref8]\] \[[@ref10]\], and others too, a reduced serum level of nitric oxide \[[@ref5]\] \[[@ref6]\] \[[@ref11]\] in pre-eclampsia compared to normal pregnant women. There is also conflicting literature as to whether the alteration in the function of the endothelium seen in pre-eclampsia results in a pathophysiologic decrease in NO synthesis \[[@ref8]\] \[[@ref10]\]. Notwithstanding the above controversies, systematic reviews and meta-analyses have shown that pre-eclamptic have a significant increased risk of incidence of cardiovascular diseases, obesity, diabetes and insulin resistance later in life \[[@ref12]\]. Thus pre-eclampsia has a huge global and economic burden. There is, therefore, the need to carry out this study to find out the role NO play in the pathophysiology of pre-eclampsia in Ghanaian women.

Methods {#sec1-2}
=======

This was a case-control study undertaken at the Korle-Bu Teaching Hospital (KBTH), Ghana between March and June 2016.

The study was conducted at the Korle-Bu Teaching Hospital, the premiere Teaching Hospital and the largest tertiary hospital affiliated with the University of Ghana School of Medicine and Dentistry. The 2000 bed capacity hospital has a 350 bed capacity with 3 operating theatre suites obstetrics and gynaecology department. The department has 65 doctors, 200 nurses and midwives, with a daily antenatal attendance of 100 patients, and a total annual delivery of between 10,000 and 12,000.

Ethical Approval for the study was obtained from the Ethical and Protocol Review Committee of University of Ghana School of Medicine and Dentistry (Protocol Identification Number: CHS-Et/M.4-P4.5/2015-2016). Clearance was also received from the Management of the Korle-Bu Teaching Hospital and Head of Obstetrics and Gynaecology department where the study was conducted.

The study population included third-trimester healthy pregnant women and pre-eclamptics aged 18-35 years attending the obstetrics and gynaecology clinic at the Korle-Bu Teaching Hospital. Patients not eligible for inclusion were:

Pregnant and pre-eclamptic on any medical treatment other than iron and folic acidPregnant and pre-eclamptic with chronic hypertension, history of kidney disease, diabetes mellitus, cardiac diseases and neuromuscular problems.

Pre-eclampsia was diagnosed using the onset of hypertension after 20 weeks of gestation with blood pressure \> 140/90 mmHg measured on two separate occasions with the coexistence of proteinuria of at least 2+ on dipstick \[[@ref13]\].

The plasma nitric oxide level for healthy pregnant women and pre-eclamptics has been found to be 63.8 and 73.3 μmol/l respectively \[[@ref14]\], with a mean difference (d) of 9.5 μmol/l. Using the formula by Charan and Biswas \[[@ref15]\], sixty (60) pregnant women in their third trimester (gestation \> 30 weeks), consisting of 30 pre-eclamptic as cases and 30 healthy pregnant women as controls were recruited consecutively into the study after obtaining informed consent.

The participants were interviewed using a structured questionnaire to obtain their demographic characteristics after signing an informed consent form. The information collected included their age, parity and gestational age. Participants subsequently had their weight and height measured using mechanical patient weighing scale with height rod (Product: 6003, Italy).

Three ml of blood was drawn from the cubital vein using a sterile 19G hypodermic needle fixed on a 5 ml syringe after cleansing the site to be punctured with methylated spirit. Aseptic conditions were adhered to. The blood sample was transferred into a sodium ethylenediamine tetraacetate (Na EDTA) test tube and prevented from clotting by gently inverting the tube 4 times manually. Nitric oxide levels were assessed in the plasma samples using the Griess Reagent system (Promega, Madison, USA). The assay relies on a diazotisation reaction that was originally described by Griess in 1879.

Patients' age, weight, height, parity, BMI and plasma nitric oxide levels were entered into Microsoft^®^ Access database 2010 (Microsoft^®^ USA), and analysis was done using statistical package for social science (SPSS^®^) software version 20.0.

The age, BMI and parity of participants, were presented as means (standard deviations) in a tabular form. The plasma nitric oxide levels between the two groups were presented in a bar chart. Independent t-test was employed to compare the difference between the mean plasma nitric oxide level of pre-eclamptic and healthy pregnant women. A *p*-value ≤ 0.05 was considered statistically significant.

Results {#sec1-3}
=======

The mean systolic, diastolic and arterial pressures were high in the pre-eclamptic compared to healthy pregnant women ([Table 1](#T1){ref-type="table"}). Age, parity and BMI were similar among the pre-eclamptic and the healthy pregnant women.

###### 

Demographic and clinical characteristics of the study sample

  Characteristic   Pre-eclamptic    Healthy pregnant women   *P*-value
  ---------------- ---------------- ------------------------ -----------------------------------------
  N                30               30                       
  Age (years)      30.97 (5.51)     29.93 (2.60)             0.358
  Parity           1.70 (1.42)      1.13 (1.41)              0.567
  BMI              32.03 (7.52)     30.50 (5.50)             0.374
  SBP              170.13 (23.69)   116.47 (13.38)           \<0.001[\*](#t1f1){ref-type="table-fn"}
  DBP              106.30 (18.79)   67.57 (8.54)             \<0.001[\*](#t1f1){ref-type="table-fn"}
  MAP              126.20 (20.86)   83.87 (8.85)             \<0.001[\*](#t1f1){ref-type="table-fn"}

Significant at *P* \< 0.05; n-sample size; SD-standard deviation; BMI-body mass index (kg/m^2^); SBP-systolic blood pressure (mmHg); DBP-diastolic blood pressure (mmHg); MAP-mean arterial pressure (mmHg).

There was no statistically significant difference in plasma nitric oxide levels in pre-eclamptic compared to healthy pregnant women (*P* = 0.160). The plasma nitric oxide levels in pre-eclamptic and healthy pregnant women were 1178.78 (89.70) nM and 1365.43 (95.46) nM respectively ([Figure 1](#F1){ref-type="fig"}).

![Mean plasma nitric oxide levels for pre-eclamptic and healthy pregnant women](OAMJMS-6-1023-g001){#F1}

A non-significant negative correlation between mean arterial pressure and plasma nitric oxide levels in pre-eclamptic was noted (Pearson Correlation Coefficient *r* = -0.072; *P* = 0.712) ([Figure 2](#F2){ref-type="fig"}).

![Correlation between mean arterial pressure and plasma nitric oxide levels in pre-eclamptic](OAMJMS-6-1023-g002){#F2}

Discussion {#sec1-4}
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This study showed a statistically non-significant difference (*P* = 0.358) between the maternal age of pre-eclamptic compared to healthy pregnant women and therefore no association of maternal age with pre-eclampsia. This is similar to the findings of other studies \[[@ref16]\] but disagrees with the findings of Macdonald-Wallis and colleagues \[[@ref17]\]. The difference in findings may be attributable to sample characteristic differences between the study populations.

This study observed a statistically non-significant difference (*P* = 0.374) in BMI between pre-eclamptic and healthy pregnant women. Therefore BMI may have no association with pre-eclampsia. This is similar to the findings of Onyebule and colleagues \[[@ref18]\] but contradicts the observations of other studies which have noted an association of elevated BMI with pre-eclampsia \[[@ref19]\].

The systolic, diastolic and mean arterial pressures of the pre-eclamptic were significantly higher compared to that of the healthy pregnant women (*P* \< 0.001). This was expected given the criteria used for diagnosis of pre-eclampsia. Mean arterial pressure is said to be predictive of pre-eclampsia even though other studies have noted otherwise \[[@ref20]\].

Our study showed a statistically non-significant reduction in plasma nitric oxide levels in pre-eclamptic compared to healthy pregnant women (*P* = 0.160) agreeing with the observations of other studies \[[@ref8]\] \[[@ref10]\]. Previous studies designed to search for a relationship between nitric oxide production in pre-eclampsia and healthy pregnancy has shown inconsistent conclusions \[[@ref9]\] \[[@ref11]\]. The supporters for increased nitric oxide levels in pre-eclamptic compared to healthy pregnant women argue that the increase is as a result of a compensatory mechanism for the occurring endothelial damage in pre-eclampsia hence an attempt to correct the vasospasm effect.

However, the supporters for decreased nitric oxide levels in pre-eclamptic as compared to healthy pregnant women suggest that the reduction is as a result of down-regulation of the nitric oxide synthase enzyme and/or occurrence of endothelial damage in the development of the disorder. The results of a statistically non-significant difference in plasma nitric oxide levels between pre-eclamptic and healthy pregnant women in this study is supported by other studies \[[@ref8]\] \[[@ref10]\]. This finding, however, may not mean that there is no association between plasma nitric oxide levels and pre-eclampsia but then as per this study, the change in nitric oxide level may not significantly impact the pathophysiology of pre-eclampsia. This may be because the determination of nitric oxide levels is confounded by several factors including a source of sample (plasma, serum, urine), a method of assaying, diet, alcohol consumption, atmospheric pollution, exercise and cigarette smoking \[[@ref21]\].

In disorders where there may be a very small difference in nitric oxide production, it may be impossible to find a significant change over the uncontrolled external factors stated above. Considering the study site, it may be very difficult eliminating the above inter-subject variations, and therefore a longitudinal study on selected subjects where inter/intra personal variations can be seen as well as any differences in nitric oxide levels throughout pregnancy between pre-eclamptic and healthy pregnant women is advised. Other studies have also admitted the contradictory reports regarding the involvement of nitric oxide in maternal adaptation to pregnancy and suggested possible multi-mechanism physiology acting in concert to maintain the pregnant mother and the foetus with the input from each mechanism being genetically determined \[[@ref22]\].

A non-significant (*P* = 0.712) negative correlation (Pearson correlation coefficient *r* = -0.072) was found between mean arterial pressure and plasma nitric oxide levels of pre-eclamptic with an *R*[@ref2] value of 0.5% implying that changes in plasma nitric oxide levels are a poor predictor of mean arterial pressures in pre-eclamptic patients.

In conclusion, this study failed to demonstrate any significant difference in plasma nitric oxide levels in pre-eclamptic compared to healthy pregnant women. Therefore, plasma nitric oxide levels may not play a significant role in the pathophysiology of pre-eclampsia.
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